Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.

Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, Kamburov A, Wood TR, Cader FZ, Ducar MD, Thorner AR, Nag A, Heubeck AT, Buonopane MJ, Redd RA, Bojarczuk K, Lawton LN, Armand P, Rodig SJ, Fromm JR, Getz G, Shipp MA.

Blood Adv. 2019 Dec 10;3(23):4065-4080. doi: 10.1182/bloodadvances.2019001012.

PMID:
31816062
2.

A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer.

Rodriguez CP, Wu Q, Voutsinas J, Fromm JR, Jiang X, Pillarisetty VG, Lee SM, Santana-Davila R, Goulart B, Baik CS, Chow LQM, Eaton K, Martins R.

Clin Cancer Res. 2019 Dec 3. pii: clincanres.2214.2019. doi: 10.1158/1078-0432.CCR-19-2214. [Epub ahead of print]

PMID:
31796519
3.

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.

Pillai V, Muralidharan K, Meng W, Bagashev A, Oldridge DA, Rosenthal J, Van Arnam J, Melenhorst JJ, Mohan D, DiNofia AM, Luo M, Cherian S, Fromm JR, Wertheim G, Thomas-Tikhonenko A, Paessler M, June CH, Luning Prak ET, Bhoj VG, Grupp SA, Maude SL, Rheingold SR.

Blood Adv. 2019 Nov 26;3(22):3539-3549. doi: 10.1182/bloodadvances.2019000692.

4.

Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.

Kim A, Stevenson P, Cassaday RD, Soma L, Fromm JR, Gopal AK, Smith SD, Till B, Lynch RC, Ujjani C, Shadman M, Warren EH, Menon M, Russell K, Tseng YD.

Pract Radiat Oncol. 2019 Oct 1. pii: S1879-8500(19)30277-2. doi: 10.1016/j.prro.2019.09.013. [Epub ahead of print]

PMID:
31585205
5.

Flow cytometric features of incidental indolent T lymphoblastic proliferations.

Fromm JR, Edlefsen KL, Cherian S, Wood BL, Soma L, Wu D.

Cytometry B Clin Cytom. 2019 Sep 30. doi: 10.1002/cyto.b.21845. [Epub ahead of print]

PMID:
31571375
7.

Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission.

Godwin CD, Fromm JR, Othus M, Sandmaier BM, Mielcarek MB, Wood BL, Appelbaum FR, Storb R, Walter RB.

Bone Marrow Transplant. 2019 Sep;54(9):1511-1514. doi: 10.1038/s41409-019-0481-9. Epub 2019 Feb 25. No abstract available.

PMID:
30804488
8.

Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.

Glynn E, Soma L, Wu D, Wood BL, Fromm JR.

Methods Mol Biol. 2019;1956:35-60. doi: 10.1007/978-1-4939-9151-8_2.

PMID:
30779029
9.

A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.

Poston JN, Fromm JR, Rasmussen HA, Shustov AR, Libby EN 3rd, Smith SD, Gooley T, Gopal AK.

Br J Haematol. 2019 Jul;186(1):159-162. doi: 10.1111/bjh.15742. Epub 2018 Dec 28. No abstract available.

PMID:
30592026
10.

Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.

Zhou Y, Moon A, Hoyle E, Fromm JR, Chen X, Soma L, Salipante SJ, Wood BL, Wu D.

Cytometry B Clin Cytom. 2019 Jan;96(1):67-72. doi: 10.1002/cyto.b.21744. Epub 2018 Nov 12.

PMID:
30417521
11.

Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma.

Grewal RK, Chetty M, Abayomi EA, Tomuleasa C, Fromm JR.

Cytometry B Clin Cytom. 2019 Mar;96(2):116-127. doi: 10.1002/cyto.b.21724. Epub 2018 Oct 22. Review.

PMID:
30350336
12.

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment.

Cader FZ, Schackmann RCJ, Hu X, Wienand K, Redd R, Chapuy B, Ouyang J, Paul N, Gjini E, Lipschitz M, Armand P, Wu D, Fromm JR, Neuberg D, Liu XS, Rodig SJ, Shipp MA.

Blood. 2018 Aug 23;132(8):825-836. doi: 10.1182/blood-2018-04-843714. Epub 2018 Jun 7.

13.

Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.

Cowan AJ, Stevenson PA, Libby EN, Becker PS, Coffey DG, Green DJ, Hyun TS, Fromm JR, Gopal AK, Holmberg LA.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1386-1391. doi: 10.1016/j.bbmt.2018.02.017. Epub 2018 Mar 1.

14.

Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia.

Ketterl TG, Wu D, Fromm JR, Soma L, Dahlberg AE, Wood BL, Tarlock K.

Bone Marrow Transplant. 2018 Mar;53(3):352-355. doi: 10.1038/s41409-017-0037-9. Epub 2017 Dec 21. No abstract available.

15.

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.

Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC 3rd, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN.

Am J Surg Pathol. 2018 Mar;42(3):293-305. doi: 10.1097/PAS.0000000000000985.

PMID:
29194092
16.

The first report of human primary thoracic spine mast cell sarcoma: a case report.

Ravanpay AC, Fromm JR, Edlefsen KL, Martin P, Chesnut R.

Clin Neuropathol. 2018 Jan/Feb;37(1):28-35. doi: 10.5414/NP301038.

PMID:
28992848
17.

Evaluation of primary mediastinal large B cell lymphoma by flow cytometry.

Cherian S, Fromm JR.

Cytometry B Clin Cytom. 2018 May;94(3):459-467. doi: 10.1002/cyto.b.21544. Epub 2017 Aug 4.

18.

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma.

Reichel JB, McCormick J, Fromm JR, Elemento O, Cesarman E, Roshal M.

J Vis Exp. 2017 Jun 10;(124). doi: 10.3791/54399.

19.

Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review.

Potts DA, Fromm JR, Gopal AK, Cassaday RD.

Case Rep Hematol. 2017;2017:2676254. doi: 10.1155/2017/2676254. Epub 2017 Feb 21.

20.

An Unusual Cause of Pulmonary Nodules After Stem Cell Transplantation.

Brady AK, Fromm JR, Kapnadak SG.

Chest. 2017 Feb;151(2):e29-e34. doi: 10.1016/j.chest.2016.11.022.

PMID:
28183501
21.

Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting.

Fromm JR, Thomas A, Wood BL.

Am J Pathol. 2017 Feb;187(2):304-317. doi: 10.1016/j.ajpath.2016.10.007. Epub 2016 Dec 18.

PMID:
27998726
22.

A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy.

Cherian S, Miller V, McCullouch V, Dougherty K, Fromm JR, Wood BL.

Cytometry B Clin Cytom. 2018 Jan;94(1):112-120. doi: 10.1002/cyto.b.21482. Epub 2016 Sep 23.

23.

A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.

Blau CA, Ramirez AB, Blau S, Pritchard CC, Dorschner MO, Schmechel SC, Martins TJ, Mahen EM, Burton KA, Komashko VM, Radenbaugh AJ, Dougherty K, Thomas A, Miller CP, Annis J, Fromm JR, Song C, Chang E, Howard K, Austin S, Schmidt RA, Linenberger ML, Becker PS, Senecal FM, Mecham BH, Lee SI, Madan A, Ronen R, Dutkowski J, Heimfeld S, Wood BL, Stilwell JL, Kaldjian EP, Haussler D, Zhu J.

J Natl Compr Canc Netw. 2016 Jan;14(1):8-17.

24.

Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.

Salipante SJ, Adey A, Thomas A, Lee C, Liu YJ, Kumar A, Lewis AP, Wu D, Fromm JR, Shendure J.

Genes Chromosomes Cancer. 2016 Mar;55(3):278-87. doi: 10.1002/gcc.22331. Epub 2015 Dec 9.

25.

Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.

Cherian S, McCullouch V, Miller V, Dougherty K, Fromm JR, Wood BL.

Cytometry B Clin Cytom. 2016 Jul;90(4):387-92. doi: 10.1002/cyto.b.21336. Epub 2015 Dec 11.

26.

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.

Cowan AJ, Stevenson PA, Cassaday RD, Graf SA, Fromm JR, Wu D, Holmberg LA, Till BG, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN 3rd, Bensinger WI, Shadman M, Maloney DG, Press OW, Gopal AK.

Biol Blood Marrow Transplant. 2016 Feb;22(2):380-385. doi: 10.1016/j.bbmt.2015.08.035. Epub 2015 Sep 5.

27.

Computer-aided detection of rare tumor populations in flow cytometry: an example with classic Hodgkin lymphoma.

Ng DP, Wu D, Wood BL, Fromm JR.

Am J Clin Pathol. 2015 Sep;144(3):517-24. doi: 10.1309/AJCPY8E2LYHCGUFP.

PMID:
26276783
28.

Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.

Wu D, Thomas A, Fromm JR.

Cytometry B Clin Cytom. 2016 Sep;90(5):424-32. doi: 10.1002/cyto.b.21261. Epub 2015 Jul 16.

29.

Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014.

Fromm JR, Tagliente DJ, Shaver AC, Neppalli V, Craig FE.

Cytometry B Clin Cytom. 2015 Nov-Dec;88(6):413-24. doi: 10.1002/cyto.b.21238. Epub 2015 May 14.

30.

Apparent CD19 expression by natural killer cells: a potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia.

Soma L, Wu D, Chen X, Edlefsen K, Fromm JR, Wood B.

Cytometry B Clin Cytom. 2015 Mar;88(2):145-7. doi: 10.1002/cyto.b.21179. Epub 2014 Aug 4.

31.

Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia.

Soma L, Wu D, Chen X, Edlefsen K, Fromm JR, Wood B.

Cytometry B Clin Cytom. 2014 Jul 21. doi: 10.1002/cytob.21179. [Epub ahead of print]

32.

Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.

Wu D, Allen CT, Fromm JR.

Cytometry B Clin Cytom. 2015 Jan;88(1):58-63. doi: 10.1002/cyto.b.21178. Epub 2014 Jul 11.

33.

Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.

Wu D, Allen CT, Fromm JR.

Cytometry B Clin Cytom. 2014 Jun 28. doi: 10.1002/cytob.21178. [Epub ahead of print]

34.

Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.

Salipante SJ, Fromm JR, Shendure J, Wood BL, Wu D.

Mod Pathol. 2014 Nov;27(11):1438-46. doi: 10.1038/modpathol.2014.57. Epub 2014 Apr 18.

35.

A six-color flow cytometry assay for immunophenotyping classical Hodgkin lymphoma in lymph nodes.

Fromm JR, Wood BL.

Am J Clin Pathol. 2014 Mar;141(3):388-96. doi: 10.1309/AJCP0Q1SVOXBHMAM.

PMID:
24515767
36.

Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin.

Chen X, Soma LA, Fromm JR.

Onco Targets Ther. 2013 Dec 19;7:45-56. doi: 10.2147/OTT.S39107. Review.

37.

Utility of flow cytometry for immunophenotyping double-hit lymphomas.

Wu D, Wood BL, Dorer R, Fromm JR.

Cytometry B Clin Cytom. 2013 Nov-Dec;84(6):398. doi: 10.1002/cyto.b.21117. Epub 2013 Aug 26. No abstract available.

38.

Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma.

Wu D, Wood BL, Fromm JR.

Methods Mol Biol. 2013;971:27-47. doi: 10.1007/978-1-62703-269-8_2.

PMID:
23296956
39.

Immunophenotyping of classical Hodgkin's lymphoma by flow cytometry.

Fromm JR, Wood BL.

Ann Hematol. 2013 Apr;92(4):569. doi: 10.1007/s00277-012-1608-x. Epub 2012 Oct 26. No abstract available.

PMID:
23100163
40.

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

Wu D, Sherwood A, Fromm JR, Winter SS, Dunsmore KP, Loh ML, Greisman HA, Sabath DE, Wood BL, Robins H.

Sci Transl Med. 2012 May 16;4(134):134ra63. doi: 10.1126/scitranslmed.3003656.

41.

Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms.

Fromm JR, McEarchern JA, Kennedy D, Thomas A, Shustov AR, Gopal AK.

Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):280-3. doi: 10.1016/j.clml.2012.01.012. Epub 2012 Apr 26. No abstract available.

PMID:
22542449
42.

Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting.

Fromm JR, Wood BL.

Methods. 2012 Jul;57(3):368-75. doi: 10.1016/j.ymeth.2012.03.028. Epub 2012 Apr 2.

PMID:
22487184
43.

Early lymph node involvement by mantle cell lymphoma limited to the germinal center: report of a case with a novel "follicular in situ" growth pattern.

Edlefsen KL, Greisman HA, Yi HS, Mantei KM, Fromm JR.

Am J Clin Pathol. 2011 Aug;136(2):276-81. doi: 10.1309/AJCP6KFFGTC8PLVR.

PMID:
21757601
44.

Diagnostic usefulness of flow cytometry for immunophenotyping classical Hodgkin lymphoma.

Fromm JR, Sabath DE, Wood BL.

Am J Clin Pathol. 2011 Jul;136(1):157-8; author reply 158. doi: 10.1309/AJCP45LUYQSOKRVE. No abstract available.

PMID:
21685044
45.

Flow cytometric evaluation of skin biopsies for mycosis fungoides.

Jokinen CH, Fromm JR, Argenyi ZB, Olerud J, Wood BL, Greisman HA.

Am J Dermatopathol. 2011 Jul;33(5):483-91. doi: 10.1097/DAD.0b013e31820595da.

PMID:
21552102
46.

Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.

Roshal M, Wood BL, Fromm JR.

Adv Hematol. 2011;2011:387034. doi: 10.1155/2011/387034. Epub 2010 Nov 28.

47.

Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma.

Fromm JR.

Cytometry B Clin Cytom. 2011 Mar;80(2):91-9. doi: 10.1002/cyto.b.20561. Epub 2010 Aug 31.

48.

"Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.

Wu D, Wood BL, Dorer R, Fromm JR.

Am J Clin Pathol. 2010 Aug;134(2):258-65. doi: 10.1309/AJCP7YLDTJPLCE5F.

PMID:
20660329
49.

Increased expression of T cell antigens on T cells in classical Hodgkin lymphoma.

Fromm JR, Thomas A, Wood BL.

Cytometry B Clin Cytom. 2010 Nov;78(6):387-8. doi: 10.1002/cyto.b.20535. No abstract available.

50.

Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.

Roshal M, Fromm JR, Winter S, Dunsmore K, Wood BL.

Cytometry B Clin Cytom. 2010 May;78(3):139-46. doi: 10.1002/cyto.b.20511.

Supplemental Content

Loading ...
Support Center